ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Phase (Ph) I/II study of sitravatinib (Sitra) alone or with tislelizumab (TIS) in advanced hepatocellular carcinoma (HCC) and gastric/gastroesophageal junction cancer (GC/ GEJC)

Li, J.; Bai, Y.; Chen, Z.; Ying, J.; Guo, Y.; Fang, W.; Zhang, F.; Xiong, J.; Zhang, T.; Meng, Z.; Zhang, J.; Yu, F.; Zhang, J.; Zhang, Z.; Qin, S.复旦大学; 安徽医科大学; 华中科技大学; 南昌大学; 南方医科大学; 哈尔滨医科大学; 浙江大学; 中国医科大学; 1
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-10DOI: 10.1016/j.annonc.2023.09.2094
10阅读
引用收藏
分享
相关
加载中…
  • Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC)
    Zhang, Feng; Bai, Yuxian; Fang, Weijia; Meng, Zhiqiang; Xiong, Jianping; Guo, Yabing; Zhang, Tao; Zhang, Jingdong; Ying, Jieer; Chen, Zhendong; Ren, Zhenggang; Chen, Yajin; Hao, Chunyi; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Wu, Xikun; Qin, ShukuiASCO Gastrointestinal Cancers Symposium, San Francisco, CA, 2022-01-20 To 2022-01-22.被引 3
  • Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC)
    Chen, Zhendong; Bai, Yuxian; Zhang, Tao; Ying, Jieer; Lin, Xiaoyan; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Huang, Ruiqi; Li, JinASCO Gastrointestinal Cancers Symposium, San Francisco, CA, 2022-01-20 To 2022-01-22.被引 1
  • Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.; Yu, X.; Gao, B.; Ma, Z.; Chu, Q.; Huang, D.; Zhao, J.; Day, D.; Body, A. L.; Pan, H.; Cui, J.; Li, H.; Sun, J.; Zhang, J.; Fei, C.; Wu, Y-L.ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK, 2022-03-07 To 2022-03-08.
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-10-20 至 2023-10-24
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-10
起止页码
S595-S596
DOI
10.1016/j.annonc.2023.09.2094
资助标注
BeiGene, Ltd.
收录
ISTP · SCIE

作者

  • L

    Li, J. (第一作者)

  • B

    Bai, Y.

    2 · harbin med univ

查看全部 15 位作者收起作者
  • C

    Chen, Z.

    2 · anhui med univ

  • Y

    Ying, J.

    zhejiang canc hosp

  • G

    Guo, Y.

    southern med univ

  • F

    Fang, W.

    1 · zhejiang univ

  • Z

    Zhang, F.

    hubei canc hosp

  • X

    Xiong, J.

    1 · nanchang univ

  • Z

    Zhang, T.

    huazhong univ sci & technol

  • M

    Meng, Z.

    fudan univ

  • Z

    Zhang, J.

  • Y

    Yu, F.

  • Z

    Zhang, J.

  • Z

    Zhang, Z.

  • Q

    Qin, S.

    nanjing univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417